Insulin Costs
During a hearing before a House Energy and Commerce Subcommittee, pharmaceutical executives faced criticism from lawmakers of both parties… read more
During a hearing before a House Energy and Commerce Subcommittee, pharmaceutical executives faced criticism from lawmakers of both parties on the rising costs of insulin. For more than two hours, committee members repeatedly asked the executives about the lack of affordability for the life-saving treatment. The executives acknowledged the high prices and outlined programs available to patients for affordable insulin. They also offered up recommendations on what Congress can do to help fix the pricing structure and market competition issues. The executives who testified came from Eli Lilly, Novo Nordisk, and Sanofi. close
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.
You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.
People in this video
More PeopleHosting Organization
Related Video
-
Prescription Drug Prices, Part 1
The House Energy and Commerce Subcommittee on Health held a hearing to examine high prescription drug prices. In the…
-
Prescription Drug Prices
The House Energy and Commerce Subcommittee on Health held a hearing to examine how to reduce prescription drug prices.…
-
States' Response to Opioid Epidemic
The House Energy and Commerce Subcommittee on Oversight and Investigations held a hearing on states' efforts to combat…
-
Opioid Distribution
Current and former executives from drug distribution companies testified at a House Energy and Commerce subcommittee…